VERASTEM, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.33 USD | +1.29% |
|
+15.24% | +61.67% |
| May. 09 | Verastem, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 14.07 | 14.07 | 13.22 |
| Spread/Res. | -6.47% | -6.47% | -0.45% |
| Spread/Supp. | +15.44% | +43.67% | +111.58% |
| Support | 11.40 | 9.160 | 6.220 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- VSTM Stock
- Charts Verastem, Inc.